Features of SRSF2-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal).

Wien Med Wochenschr · 2025 · PMC12380958 · PMID 40549056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

The proportion of patients with thrombocytopenia < 100 G/L was significantly higher in SRSF2 -mutated patients in the ABCMML cohort and the difference was of borderline significance in the cBioPortal cohort.

also in 1,681 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.